Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

During the Trading Day
335.27 -0.65 / -0.19%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
335.25 -0.02 / -0.01%
Volume: 100.00

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by NASDAQ OMX. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.


1 month+6.58% 3 years+34.57%
3 months-1.37% 5 years+30.92%
1 year+13.91% Since inception+8.68%
Data through 11/24/2015

Quote Details

Previous close$335.92
Open day’s range331.50 – 335.72
Net asset value (NAV)335.70 (11/23/2015)
Daily volume1,134,806
Average volume (3 months)2,708,989
Data as of 3:59pm ET, 11/24/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+30.92%+20.45%
Expense Gross exp ratio0.48%0.47%
Risk 5 year sharpe ratio1.481.34
Net assets$8.2B$1.7B
Average market cap$19.8B$35.0B
Average P/E23.624.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.76%
CELG Celgene8.73%
REGN Regeneron Pharmaceuticals8.69%
GILD Gilead Sciences8.65%
BIIB Biogen8.21%
ALXN Alexion Pharmaceuticals Inc4.29%
VRTX Vertex Pharmaceuticals Inc4.11%
MYL Mylan NV3.50%
INCY Incyte Corp3.42%
ILMN Illumina Inc3.05%